Studies from EMD Serono Research Institute Have Provided New Data on Cancer (The preclinical pharmacology of tepotinib - a highly selective MET inhibitor with activity in tumors harboring MET alterations).

Předmět:	PHARMACOLOGY CATECHOL-O-methyltransferase RESEARCH institutes PROTEIN-tyrosine kinases
Zdroj:	Drug Week; 4/21/2023, p1005-1005, 1p
Abstrakt:	Keywords: Biopharmaceutical Companies; Business; Cancer; Drugs and Therapies; Enzymes and Coenzymes; Health and Medicine; Healthcare Biotechnology Companies; Kinase; Oncology; Pharmaceuticals; Pharmacology; Proteins; Proteomics; Tyrosine Kinase EN Biopharmaceutical Companies Business Cancer Drugs and Therapies Enzymes and Coenzymes Health and Medicine Healthcare Biotechnology Companies Kinase Oncology Pharmaceuticals Pharmacology Proteins Proteomics Tyrosine Kinase 1005 1005 1 04/17/23 20230421 NES 230421 2023 APR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in cancer. Biopharmaceutical Companies, Business, Cancer, Drugs and Therapies, Enzymes and Coenzymes, Health and Medicine, Healthcare Biotechnology Companies, Kinase, Oncology, Pharmaceuticals, Pharmacology, Proteins, Proteomics, Tyrosine Kinase. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu